Intriguingly, surface FcμR levels were also significantly elevated in non-CLL B cells (CD19+/CD5−) and T cells (CD19−/CD5+), especially in patients with IGHV-mutated CLL, when compared with the corresponding populations in healthy individuals. Here, FCMR is linked to B-cell chronic lymphocytic leukemia.